First Republic Investment Management, Inc. Acadia Pharmaceuticals Inc Transaction History
First Republic Investment Management, Inc.
- $34.7 Billion
- Q3 2023
A detailed history of First Republic Investment Management, Inc. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 10,000 shares of ACAD stock, worth $168,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 11,058
9.57%
Holding current value
$168,700
Previous $264,000
21.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ACAD
# of Institutions
279Shares Held
156MCall Options Held
901KPut Options Held
314K-
Baker Bros. Advisors LP New York, NY42.9MShares$723 Million7.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.8MShares$234 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$231 Million3.36% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$203 Million0.0% of portfolio
-
State Street Corp Boston, MA5.97MShares$101 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.73B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...